Skip to main content
Log in

Bessere Heilungsraten, aber wie steht es um das postmetastatische Überleben?

Folgen der adjuvanten Therapie bei Brustkrebs

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Schlesinger-Raab A et al. Dtsch. Arztebl. 2005;102:A2706–13.

    Google Scholar 

  2. Kleeberg UR et al. Onkologie. 2013;36(6):348–56.

    Article  CAS  PubMed  Google Scholar 

  3. Fink MK et al Oncologist. 2015;20(1):88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kleeberg UR. Senologie. 2009;6(2):80–2.

    Google Scholar 

  5. Kleeberg UR. Umwelt Medizin Gesellschaft. 2017;30(1):12–5.

    Google Scholar 

Originalie

  • Hölzel D et al. Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern und shortens post-metastatic survival: 35-year results from the Munich Cancer registry. J Cancer Res Clin Oncol. 2017 Apr 20. [Epub ahead of print].

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulrich R. Kleeberg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kleeberg, U.R., Fink, M. Folgen der adjuvanten Therapie bei Brustkrebs. Info Onkol. 20, 20–22 (2017). https://doi.org/10.1007/s15004-017-5738-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-017-5738-0

Schlüsselwörter

Navigation